Transmedics Group Inc
(TMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 143,823 | 157,370 | 143,537 | 121,624 | 108,761 |
| Cost of Goods | 59,248 | 60,781 | 55,309 | 49,611 | 47,916 |
| Gross Profit | 84,575 | 96,589 | 88,228 | 72,013 | 60,845 |
| Operating Expenses | 61,523 | 60,803 | 61,094 | 63,980 | 57,838 |
| Operating Income | 23,300 | 36,567 | 27,443 | 8,644 | 3,923 |
| Interest Expense | 3,491 | 3,476 | 3,461 | 3,571 | 3,617 |
| Other Income | 3,222 | 3,091 | 2,694 | 1,916 | 3,939 |
| Pre-tax Income | 23,031 | 36,182 | 26,676 | 6,989 | 4,245 |
| Income Tax | -1,288 | 1,275 | 994 | 132 | 29 |
| Net Income Continuous | 24,319 | 34,907 | 25,682 | 6,857 | 4,216 |
| Net Income | $24,319 | $34,907 | $25,682 | $6,857 | $4,216 |
| EPS Basic Total Ops | 0.71 | 1.03 | 0.76 | 0.20 | 0.13 |
| EPS Basic Continuous Ops | 0.71 | 1.03 | 0.76 | 0.20 | 0.13 |
| EPS Diluted Total Ops | 0.66 | 0.92 | 0.70 | 0.19 | 0.12 |
| EPS Diluted Continuous Ops | 0.60 | 0.86 | 0.64 | 0.19 | 0.12 |
| EPS Diluted Before Non-Recurring Items | 0.66 | 0.92 | 0.70 | 0.19 | 0.12 |
| EBITDA(a) | $30,149 | $43,298 | $33,580 | $14,324 | $9,100 |